Avid Bioservices Inc (CDMO)

[keep_trying]

djohn, Ronin offering nothing more than a plan that involves monetizing the Avid value current leadership has been developing makes the food fight analogy appropriate, methinks. Food fights make a mess, don't accomplish much productive of themselves and enable mischief to avoid notice through diversion.

I am looking for substance from Ronin that suggests that they are offering more than a path that might set back PPHM technology commercialization. So far, I observe a pps swing that appears to be financially benefiting others (not me, as I have held my shares and bought a few more per pre-Ronin entry plan at a higher price than I might have otherwise had to pay.

I see value realization from PPHM coming together when Avid's customer base gets consolidated and strengthened (Halozyme has reduced orders) so that Avid can reach that $100 million + annual sales threshold. Avid expansion planning has already been set up to support that. I also see value realization coming from PPHM when the PPHM tech gets aligned with partnering that brings value to patients, applying the significant discoveries of Dr. Thorpe and others. Some have said that there has been no value demonstrated, but I do my own review of PPHM developments and I am not convinced that the real issue isn't just that pharma doesn't want to pay the price that the current BOD has been seeking. Maybe Ronin's lower expectations for the technology value will make those Pharma more happy? Maybe there is no value there, like Ronin suggests?

Best wishes and IMO.
KT